Mr. Martin Fraser:

All that paragraph says is that essentially, he wanted to move on from the CMO role and it would be to a "public policy development role outside of the Department of Health". That is a far more generic sort of proposal than the proposal which I understand has given rise to the controversy, which is the secondment proposal. I only discussed the secondment proposal, the specific one that we are now engaged in talking about, in February.